- Brand origin
- Sweden
- Main production
- Portugal
A Swedish generic pharmaceutical company founded in 2005, focusing on licensing, developing, and distributing affordable generic prescription pharmaceuticals across Europe.
Is the information about Atorbir correct?
Updated: 18 September 2026 ·
About Atorbir
Subsidiaries: Bluefish Pharmaceuticals AB
Ownership data is compiled from public sources and verified where possible. Spotted an error? Suggest a correction below.
